The International Prognostic Index (IPI) score in lymphoma was comparable between HBsAg+ patients and HBsAg−/anti-HBc+ patients, and it was also comparable among the HBsAg+ subgroups (HBV DNA positive and HBV DNA negative). Here, KRT88P is linked to lymphoma.